In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus. (2022)
Attributed to:
Developing a cocktail of enzyme inhibitors to universally treat haemotoxicity caused by snakebite
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.toxcx.2022.100118
PubMed Identifier: 35321116
Publication URI: http://europepmc.org/abstract/MED/35321116
Type: Journal Article/Review
Volume: 14
Parent Publication: Toxicon: X
ISSN: 2590-1710